Baird Medical Showcases Advanced MWA Technology to UCLA Expert – China

Baird Medical Investment Holdings Ltd. recently hosted Dr. Gary G. Tse, a prominent interventional radiologist from UCLA Health, for an immersive clinical and academic exchange in Guangzhou, China. This strategic engagement aimed to demonstrate the clinical capabilities of Baird Medical’s advanced microwave ablation (MWA) system and foster deeper international collaboration in thyroid health innovation.

Dr. Tse’s visit included live procedural observations at the esteemed Sun Yat-sen University Cancer Center, where he witnessed the MWA technology in action during multiple thyroid nodule ablation treatments. The hands-on experience offered Dr. Tse an opportunity to closely evaluate the precision, safety profile, and therapeutic effectiveness of the system — reinforcing the value of MWA as a minimally invasive, patient-centric alternative to conventional thyroid surgery.

The visit also featured high-level academic dialogue with Dr. Michael Mingzhao Xing, Professor Emeritus of Medicine at the Johns Hopkins University School of Medicine, who joined discussions on evolving global standards for thyroid nodule diagnosis and treatment. Together, the experts examined recent clinical data, procedural techniques, and innovation pathways shaping the future of endocrine therapies.

This cross-border initiative reflects Baird Medical’s unwavering commitment to clinical excellence, scientific collaboration, and global market growth. By connecting with world-renowned specialists, the company continues to position its MWA technology at the forefront of thyroid care, promoting access to safer, less invasive solutions for patients worldwide.

As Baird Medical advances into new international markets, such visits underscore its mission to elevate global healthcare outcomes through cutting-edge technology, medical education, and expert partnerships.